Anxiety and Related Sleep Disorders - Egypt

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$91.71m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.18%, resulting in a market volume of US$102.10m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$13.38 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Egypt has seen significant growth in recent years, driven by changing customer preferences and increasing awareness of mental health issues. Customer preferences in the Anxiety and Related Sleep Disorders market in Egypt have shifted towards more natural and holistic remedies. Consumers are increasingly looking for products that are derived from natural ingredients and have fewer side effects. This trend is in line with the global market, where there has been a growing demand for alternative therapies and natural remedies. Trends in the market show that there is a rising prevalence of anxiety and related sleep disorders in Egypt. This can be attributed to several factors, including the increasing stress levels in the population, changing lifestyles, and the impact of social media. The fast-paced nature of modern life has led to high levels of stress and anxiety, which in turn has contributed to an increase in sleep disorders. Additionally, the widespread use of social media has also been linked to higher levels of anxiety and sleep problems.Local special circumstances in Egypt have also played a role in the development of the Anxiety and Related Sleep Disorders market. The country has a large and growing population, which provides a significant market for mental health products and services. Furthermore, the Egyptian government has recognized the importance of mental health and has taken steps to improve access to mental health care and raise awareness about mental health issues. This has created opportunities for companies in the Anxiety and Related Sleep Disorders market to expand their operations and reach a wider customer base.Underlying macroeconomic factors have also contributed to the growth of the Anxiety and Related Sleep Disorders market in Egypt. The country has experienced economic growth in recent years, leading to an increase in disposable income and higher spending power. As a result, consumers are more willing to invest in products and services that can improve their mental well-being, including those related to anxiety and sleep disorders.In conclusion, the Anxiety and Related Sleep Disorders market in Egypt has experienced significant growth due to changing customer preferences, increasing awareness of mental health issues, and underlying macroeconomic factors. The market is expected to continue to expand in the coming years as the demand for natural and holistic remedies for anxiety and sleep disorders continues to rise.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.